---
title: "小仓位过过日子"
type: "Profile"
locale: "en"
url: "https://longbridge.com/en/profiles/27571747.md"
datetime: "2026-07-18T12:34:06.661Z"
locales:
  - [en](https://longbridge.com/en/profiles/27571747.md)
  - [zh-CN](https://longbridge.com/zh-CN/profiles/27571747.md)
  - [zh-HK](https://longbridge.com/zh-HK/profiles/27571747.md)
---

# 小仓位过过日子 — Longbridge Community Profile

## User Info

| Item | Detail |
|------|--------|
| Name | 小仓位过过日子 |
| Profile URL | https://longbridge.com/en/profiles/27571747 |
| Followers | 0 |
| Following | 1 |
| Posts | 29 |
| Topics | 28 |
| Likes Received | 11 |

## Recent Activities (15)

- [$AKESO(09926.HK) dropped over ten percent, $3SBIO(01530.HK) followed closely, and $CSPC PHARMA(01093](https://longbridge.com/en/news/42764702.md) — *2026-07-17T10:30:53.000Z*
- [$Regencell Bioscience(RGC.US) has dropped over nine points, declining on low volume. Days without ne](https://longbridge.com/en/news/42719594.md) — *2026-07-16T10:45:48.000Z* (💬 1)
- [$WUXI APPTEC(02359.HK) and $Tempus AI(TEM.US) both rose four to five percent, with stories of CRO de](https://longbridge.com/en/news/42682420.md) — *2026-07-15T10:38:40.000Z* (👍 1)
- [$REMEGEN(09995.HK), $TRANSTHERA-B(02617.HK), and $ALI HEALTH(00241.HK) all rose slightly 😀The bulli](https://longbridge.com/en/news/42618275.md) — *2026-07-13T10:51:18.000Z*
- [$WUXI BIO(02269.HK) rose nearly four percentage points, as Hong Kong's CXO sector followed the recov](https://longbridge.com/en/news/42543392.md) — *2026-07-09T10:59:42.000Z*
- [$Structure Therapeutics(GPCR.US) rose by more than three points. Oral GLP-1 weight-loss drug Phase I](https://longbridge.com/en/news/42512412.md) — *2026-07-08T10:51:12.000Z*
- [$REMEGEN(09995.HK) rose over nine percentage points to lead the gains; the logic behind license-out ](https://longbridge.com/en/news/42420152.md) — *2026-07-03T11:04:42.000Z*
- [$Shopify (SHOP.US) dipped slightly, and $ALI HEALTH(00241.HK) fell a bit. The e-commerce and online ](https://longbridge.com/en/news/42312807.md) — *2026-06-30T10:56:21.000Z*
- [$WUXI BIO(02269.HK) and $BEONE MEDICINES(06160.HK) rose slightly, while $INSILICO(03696.HK) basicall](https://longbridge.com/en/news/41766716.md) — *2026-06-12T10:42:56.000Z*
- [$SpaceX(SPCX.US) lists today at a $135 price and a $1.75 trillion valuation—the largest IPO in histo](https://longbridge.com/en/news/41751898.md) — *2026-06-12T03:33:11.000Z*
- [$TENNOR THERAP-B(06872.HK) and $MABWELL-B(02493.HK) both rose four or five points. The clinical cata](https://longbridge.com/en/news/41716241.md) — *2026-06-11T11:02:06.000Z*
- [$Tempus AI(TEM.US) rose by four or five points, the AI-assisted diagnosis and data sector still has ](https://longbridge.com/en/news/41626248.md) — *2026-06-09T11:00:05.000Z*
- [$Oscar Health(OSCR.US) has hit another 52-week high, rising over ten percent. Money has been continu](https://longbridge.com/en/news/41625850.md) — *2026-06-09T10:57:31.000Z*
- [Moderna rose by seven or eight percentage points, one of the top gainers in U.S. biotech stocks toda](https://longbridge.com/en/news/41475127.md) — *2026-06-04T10:52:20.000Z* (👍 1)
- [Xiaomi Auto delivered over 410,000 vehicles in 2025, with revenue exceeding 100 billion RMB, but its](https://longbridge.com/en/news/41363207.md) — *2026-06-02T04:55:17.000Z* (👍 2 · 💬 3)

## Following (1)

- [LongbridgeAI](https://longbridge.com/en/profiles/10010333.md) — Bridge your way to the world of investment
跨越信息鸿沟，探索投资世界

## Recently Viewed Stocks (10)

- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [9995.HK](https://longbridge.com/en/quote/9995.HK.md)
- [6872.HK](https://longbridge.com/en/quote/6872.HK.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [WXXWY.US](https://longbridge.com/en/quote/WXXWY.US.md)
- [2269.HK](https://longbridge.com/en/quote/2269.HK.md)
- [688331.SH](https://longbridge.com/en/quote/688331.SH.md)
- [1609.HK](https://longbridge.com/en/quote/1609.HK.md)
- [1530.HK](https://longbridge.com/en/quote/1530.HK.md)
- [1187.HK](https://longbridge.com/en/quote/1187.HK.md)


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**